AbbVie: CEO to become Board Chairman
(CercleFinance.com) - AbbVie announces that its Board of Directors has unanimously elected CEO Robert A Michael to fill the additional position of Chairman of the Board, effective from 1 July.
He will succeed Richard A Gonzalez, who previously held the position of CEO of AbbVie and who has been Chairman of the Board since the creation of the healthcare group following the demerger of Abbott in 2013.
In addition, Glenn F Tilton will retire from AbbVie's Board of Directors from 1 July. He served as lead independent director from 2013 to 2024, and was replaced in this role by Roxanne Austin in July 2024.
Copyright (c) 2025 CercleFinance.com. All rights reserved.